David Thompson, PhD is a health economist who has been working in the field of HEOR since 1988. During the course of his career, he has developed expertise in economic modeling, retrospective database analysis, prospective real-world research, and patient-reported outcomes. His work has been global in nature, with extensive experience in North American & European markets as well as the emerging markets of the Asia-Pacific and Latin American regions. Dave is Senior Vice President, Real-World Research, at Syneos Health, a position he has held since 2016. Prior to joining Syneos Health, he held leadership positions at Quintiles (2012-2016), i3 Innovus/OptumInsight (2000-2012) and PAI (1988-2000).
The global pandemic radically accelerated changes in our industry, including the rapid uptake of decentralized clinical trials. Now that the dust is settling, it is important to better understand the many options and technologies available in our toolbox and to apply these in a thoughtful way in order to ensure trial success. This panel discussion will address key considerations for applying decentralized solutions for oncology including the long term follow-up aspects to meet the needs of multiple stakeholders, including sites, patients, regulators and payers.